Browsing by Author "Danquah, Cynthia Amaning"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Anti-Inflammatory and antinociceptive effects of the root extract of capparis Erythrocarpos Isert (Capparaceae)
    (2008) Danquah, Cynthia Amaning
    Capparis erythrocarpos (Capparaceae) commonly called 'capers' is reputed traditionally in Ghana and other parts of Africa for the management of various inflammatory and pain conditions. The objective of this study was to evaluate the anti-inflammatory, antinociceptive, antipyretic and toxicological properties of the ethanolic root extract using various animal models. Preliminary phytochemical screening showed that the extract contained alkaloids, flavonoids and terpenoids. Acute inflammation was evaluated using carrageenan-induced foot edema in the 7-day-old chick with diclofenac and dexamethasone as reference drugs. Pre treatment with the extract (10-300 mg kg1; p.o.) significantly (F^ioo=3.69, P=0.02), inhibited foot oedema in the chicks with maximal inhibition of 48.86±20.41 %; however, the effect was U-shaped. Diclofenac and dexamethasone dose-dependently inhibited carrageenan-induced foot oedema. Chronic inflammation was evaluated using adjuvant-induced arthritis in rats with dexamethasone and methotrexate as reference drugs. Treatment with the extract (30 mg kg"1; p.o.) significantly (F3,i6=4.25, P=0.02), suppressed adjuvant-induced arthritis with maximal inhibitions of 34.19±15.73 % and also significantly (F3,16=4.28, P-0.02) prevented the spread of arthritis from the ipsilateral to the contralateral paw. Extract (100-300 mg kg"1; p.o.) had weak anti-arthritic effect Results from the prophylactic and combination protocol suggest that C. erythrocarpos (100 mg kg"1; p.o.) therapy alone was not able to significantly ameliorate adjuvant-induced arthritis when administered prophylactically. In contrast amelioration of adjuvant-induced arthritis by combined effect of C. erythrocarpos (100 mg kg1; p.o) and dexamethasone (1 mg kg"1; i.p.); C. erythrocarpos (100 mg kg"1; p.o) and methotrexate (0.3 mg kg"1; i.p.) were established. When combined with dexamethasone, there was a significant inhibition of arthritis in both the acute (P<0.05) and the polyarthritic (P<0.001) phases. In combination with methotrexate, there was no significant effect in the acute phase (P>0.05) but significant inhibition (P<0.05) occurred in the polyarthritic phase. Antinociceptive effect of G erythrocarpos extract (10-300 mg kg"1; p.o.) was evaluated using the formalin-induced pain model with morphine (1-10 mg kg"1; i.p.) as reference drug. The effects following naloxone and theophyline pretreatment were also studied. The results showed that the extract dose- dependently inhibited both phases of formalin-induced pain. The extract (100 mg kg significantly reduced formalin-induced nociception with a percentage inhibition of 47.54±5.65 % (F3/16 =15.25; P< 0.0001) in the first phase and 80.01±3.77 % (F3/i6= 35.34; P < 0.0001) in the second phase. Naloxone did not reverse the antinociceptive effect of the extract in both the neurogenic phase 43.44±4.15 % and the inflammatory phase 82.41±0.90 %; however, theophyline significantly and completely reversed the first phase and significantly but partially reversed the second phase with percentage inhibition of 57.08±1.88 %. C. erythrocarpos (30-300 mg kg"1; p.o.) dose-dependently decreased baker's yeast induced fever. Paracetamol (10-100 mg kg"1; p.o.) was used as the reference drug. In the toxicity study, using high concentrations of the extract (0.3-3 g kg"1 p.o.) there were no significant differences found in most of the haematological indices, serum biochemical parameters and organ/body weight ratios hence the extract has a high safety profile. In summary, G erythrocarpos has anti-inflammatory, antinociceptive and anti pyretic activity and these findings support the use of the extract in traditional medicine.  
  • No Thumbnail Available
    Item
    Aurantio-obtusin alleviates allergic responses in ovalbumin-induced rhinitis
    (Scientific African, Elsevier, 2023-11-30) Nyarko, Mavis Sersah; Danquah, Cynthia Amaning; Antwi, Aaron Opoku
    Allergic rhinitis (AR) is a growing global health concern. Despite being non-fatal, it has a detrimental effect on people’s quality of life and poses a significant economic burden. In this study, we aimed to evaluate the anti-allergic effects of aurantio-obtusin against ovalbumin-induced murine model of allergic rhinitis. Aurantio-obtusin was administered to rats orally after sensitization to ovalbumin. Results of the study suggested that aurantio-obtusin causes a significant reduction in nose rubs and sneeze as compared to the vehicle-treated disease control group. The aurantioobtusin treated group showed a dose-dependent significant reduction in serum TNF-α, IL-4, and IL-6 levels as well as histamine levels in the nasal mucosa. Additionally, it decreased neutrophil and eosinophil numbers in blood of AR rats’. In the nasal tissues of the vehicle-treated rats that were subjected to an OVA challenge, the histology of the nasal mucosa of AR rats revealed aberrant histological changes. A variety of histological abnormalities, including vascular congestion in the nasal mucosa, substantial inflammatory cell infiltration, and obvious alveolar wall oedema were present. In the rats treated with aurantio-obtusin, these characteristics were reversed. Collectively, the findings suggests that aurantio-obtusin could be used to enhance current AR treatment approaches.